Screener
GKAT vs PCRB
Scharf Global Opportunity ETF vs Putnam ESG Core Bond ETF -
Key differences
GKAT is an equity ETF, while PCRB is a fixed income ETF. GKAT charges 0.59% a year and PCRB 0.36%.
- GKAT is an equity fund, while PCRB is a fixed income fund. They carry different risk/return profiles.
- GKAT follows a active selection strategy; PCRB uses index tracking.
- GKAT covers global markets; PCRB covers North America.
- PCRB costs 0.23% less per year.
- GKAT is much larger than PCRB. Larger funds are usually more liquid and less likely to close.
- GKAT has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| GKAT | PCRB | |
|---|---|---|
| Annual cost (TER) | 0.59% | 0.36% |
| Fund size (AUM) | $165M | $7M |
| Since | 2014 | 2023 |
| Dividend yield | 0.45% | 9.74% |
| Asset class | equity | fixed income |
| Region | global | north america |
| Strategy | active selection | index tracking |
| CAGR 1Y | N/A | +3.5% |
| CAGR 3Y | N/A | +3.9% |
| CAGR 5Y | N/A | N/A |
| Sharpe 3Y | N/A | 0.07 |
| Volatility 1Y | — | 3.76% |
| Max drawdown | -10.41% | -7.20% |
Beyond the comparison: Beacon helps you build, track, and project a portfolio with the ETFs you pick.